The Problem That Started Everything

Medical journals publish thousands of studies every year. Each one represents months or years of rigorous research, careful peer review, and hard-won clinical insight. And then, overwhelmingly, they sit. They sit in databases behind paywalls. They sit in PDF format, locked in static tables and dense prose that even specialists struggle to revisit. A landmark study with the power to change clinical decisions at the bedside reaches, on average, a fraction of the clinicians who need it and almost none of the patients whose lives depend on it.

This is not a knowledge problem. The evidence exists. The data has been collected, analyzed, peer-reviewed, and published. The failure is in the last mile: getting that evidence from the journal page to the point of care in a form that is usable, explorable, and understandable by both the clinician making the decision and the patient living with the outcome.

That gap is what LiveEvidence was built to close.

I spent five decades reading the evidence. I spent the last eighteen months figuring out how to make it live.

Two Years of Trial, Error, and One Working Method

LiveEvidence did not begin as the platform you see today. It began as a question: could the data inside peer-reviewed publications be extracted, structured, and re-presented in a way that preserved its scientific integrity while making it genuinely interactive?

The answer, for a long time, was no.

The first attempts, beginning in early 2023, focused on conventional approaches to data transformation. Standard extraction pipelines. Traditional programming frameworks. Off-the-shelf visualization libraries applied to manually transcribed datasets. Each attempt produced something technically functional but clinically inadequate. The tools were either too rigid to accommodate the complexity of real clinical data, too fragile to maintain fidelity when studies used different methodologies, or too generic to be useful at the bedside.

The fundamental challenge was not technical but epistemological. Medical publications are not uniform. A risk ratio from a cohort study does not behave like an odds ratio from a case-control design. A confidence interval from an IPD meta-analysis carries different interpretive weight than one from an aggregate analysis. An adjusted hazard ratio controlling for twelve covariates means something different than an unadjusted one. Any system that treats these as interchangeable will produce tools that look sophisticated but are clinically misleading.

Over two years, through dozens of iterations and false starts, Structured Collaboration™ (SC Coding©) gradually emerged. Developed by Dr. Grünebaum, it is not a single breakthrough but a layered system of structured interpretation, evidence synthesis, and output generation that can reliably transform the heterogeneous landscape of medical publications into interactive tools that clinicians actually trust. The AI drafts. The clinician directs, reviews, and executes. Professional oversight is non-negotiable, and the structure is defined on the human side before the AI writes a single line.

What changed was not a single technology but a discipline. Structured Collaboration™ sits between two approaches that each sacrifice something essential in clinical work. Fully autonomous AI removes the physician. Vibe coding makes the physician a rubber stamp. Neither is acceptable when the output reaches a patient. SC is the working answer: physician-defined structure, AI-assisted drafting, clinician-verified output. Every time.

The LiveEvidence Process

Each tool on this platform passes through a six-phase Structured Collaboration™ pipeline that ensures the final product is not merely a visualization of data, but a faithful, clinician-verified representation of the published evidence. The principles that govern it are transparent — because transparency is the point.

Phase I

Source Identification and Validation

Every tool begins with one or more peer-reviewed publications. These are not selected at random. Each source is evaluated for methodological rigor, clinical relevance, sample size adequacy, and the specificity of its reported outcomes. Publications that rely on surrogate endpoints, use non-standard statistical methods without adequate justification, or report findings that cannot be independently verified are excluded.

Where multiple publications address the same clinical question with conflicting findings — which is more common than most clinicians realize — the source selection process incorporates a structured assessment of study quality, population generalizability, and statistical power to determine which data points merit inclusion and how they should be weighted relative to one another.

Phase II

Structured Evidence Extraction

Raw data extraction from medical publications is deceptively complex. The same outcome may be reported as a relative risk in one study, an odds ratio in another, and an absolute risk difference in a third. Follow-up periods vary. Adjustment models differ. Subgroup definitions overlap but do not align. A tool that simply lifts numbers from a table without understanding their statistical context will mislead.

The LiveEvidence extraction methodology applies a proprietary analytical framework that accounts for these inconsistencies. Each data point is tagged with its statistical provenance: the study design from which it originates, the adjustment model applied, the population subset it represents, and the precision of its estimate. This metadata layer is invisible to the end user but is the foundation upon which every calculation, comparison, and visualization in the tool rests.

Phase III

Clinical Logic Architecture

This is where LiveEvidence diverges most fundamentally from conventional data visualization. A standard chart or calculator takes inputs and produces outputs. A LiveEvidence tool embeds clinical reasoning into its architecture. Validation rules prevent clinically impossible combinations. Contextual guidance surfaces at decision points. Dual-audience rendering presents the same underlying data at a level appropriate for the user — whether that user is a maternal-fetal medicine specialist or a patient at 32 weeks.

The clinical logic layer is built by a physician with over fifty years of clinical experience in obstetrics and gynecology. This is not algorithmic approximation of medical knowledge. It is the direct encoding of clinical expertise, peer-reviewed evidence, and real-world practice patterns into the tool's decision architecture.

Phase IV

Multi-Source Synthesis and Calibration

Many LiveEvidence tools draw on more than one publication. When they do, the synthesis process follows a structured reconciliation protocol. Overlapping datasets are identified and deduplicated. Complementary findings are integrated using a proprietary weighting system that accounts for study quality, recency, and population specificity. Conflicting results are not hidden but are surfaced transparently, with the tool's outputs reflecting the best available synthesis rather than any single study's conclusions.

This synthesis capability is what allows LiveEvidence tools to be more precise than any individual publication. A single study captures one population at one time. A well-synthesized tool captures the convergent signal across multiple studies, filtered through clinical logic and statistical rigor.

Phase V

Validation and Clinical Review

Before any tool is published, it undergoes a verification process in which every output is traced back to its source data. Calculated values are checked against the original publication tables. Edge cases are tested. Clinical scenarios that would be rare but possible in practice are run through the tool to confirm that it behaves appropriately. There is no automated shortcut for this step. Every tool is reviewed by the same physician who designed it.

Phase VI

Accessibility and Multilingual Deployment

Clinical tools that only work in one language for one audience fail most of the people who need them most. LiveEvidence tools are built from the ground up with multilingual support — currently spanning up to seven languages — and dual-audience rendering that adapts the same evidence for clinician and patient contexts. Every translation preserves clinical precision. Every patient-facing explanation is written at a 7th to 8th grade reading level without sacrificing scientific accuracy.

Structured Collaboration™ is the method. The evidence is still yours. Every number you see comes from a published, peer-reviewed source — and we will always tell you which one.

Why This Matters

There are many medical calculators on the internet. Most of them take a formula from a single study, wrap it in a form, and call it a tool. They are technically correct and clinically incomplete. They do not account for the complexity of how evidence accumulates, conflicts, and resolves across a body of literature. They do not adapt to their audience. They do not embed the clinical judgment that determines whether a statistical finding is relevant to the patient in front of you.

LiveEvidence tools are different because the method that built them is different. Structured Collaboration™ does not digitize a formula. It encodes the full weight of published evidence — with all its complexity, nuance, and occasional contradiction — into tools accessible at the point where decisions are made, verified by the physician who designed them. It took two years to build. It produces tools that did not previously exist.

Every tool is free. Every tool is open access. The evidence belongs to everyone. LiveEvidence simply makes it usable.

Amos Grünebaum, MD
Creator, LiveEvidence
Professor of Obstetrics & Gynecology
Maternal-Fetal Medicine Specialist
Dr. Grünebaum has spent over fifty years in clinical obstetrics and gynecology, with a focus on high-risk pregnancy, evidence-based practice, and medical ethics. He is the creator of LiveEvidence, publisher of ObGyn Intelligence, and a longstanding advocate for making medical evidence accessible to both clinicians and the patients they serve. LiveEvidence is the product of his conviction that published data should not remain static on a page when it has the potential to improve care at the bedside.